Vaccination with a Plasmodium chabaudi adami multivalent DNA vaccine cross protects A/J mice against challenge with P. c. adami DK and virulent P. c. chabaudi AS parasites

Tatiana Scorza, Kim Grubb, Mathieu Cambos, Cynthia Santamaria, D. Malu, Terry Spithill

Research output: Contribution to journalArticle

6 Citations (Scopus)
5 Downloads (Pure)

Abstract

A current goal of malaria vaccine research is the development of vaccines that will cross-protect against multiple strains of malaria. Inthe present study, the breadth of cross-reactivity induced by a 30K multivalent DNA vaccine has been evaluated in susceptible A/J mice(H-2a) against infection with the Plasmodium chabaudi adami DK strain and a virulent parasite subspecies, Plasmodium chabaudi chabaudi AS. Immunized A/J mice were significantly protected against infection with both P. c. adami DK (31'40% reduction in cumulativeparasitemia) and P. c. chabaudi AS parasites, where a 30'39% reduction in cumulative parasitemia as well as enhanced survival wasobserved. The 30K vaccine-induced specific IFN-c production by splenocytes in response to native antigens from both P. c. chabaudi AS and P. c. adami DK. Specific antibodies reacting with surface antigens expressed on P. c. adami DS and P. c. chabaudi AS infected red blood cells, and with opsonizing properties, were detected. These results suggest that multivalent vaccines encoding conserved antigenscan feasibly induce immune cross-reactivity that span Plasmodium strains and subspecies and can protect hosts of distinct major histocompatibility complex haplotypes.
Original languageEnglish
Pages (from-to)819-827
Number of pages9
JournalInternational Journal for Parasitology
Volume38
Issue number7
DOIs
Publication statusPublished - 2008

Fingerprint

Plasmodium chabaudi
DNA Vaccines
Parasites
Vaccination
Vaccines
Malaria Vaccines
Plasmodium
Parasitemia
Surface Antigens
Infection
Major Histocompatibility Complex
Haplotypes
Malaria
Erythrocytes
Antigens
Antibodies
Research

Cite this

Scorza, Tatiana ; Grubb, Kim ; Cambos, Mathieu ; Santamaria, Cynthia ; Malu, D. ; Spithill, Terry. / Vaccination with a Plasmodium chabaudi adami multivalent DNA vaccine cross protects A/J mice against challenge with P. c. adami DK and virulent P. c. chabaudi AS parasites. In: International Journal for Parasitology. 2008 ; Vol. 38, No. 7. pp. 819-827.
@article{23332c09fa904bc3b86d87def9db0936,
title = "Vaccination with a Plasmodium chabaudi adami multivalent DNA vaccine cross protects A/J mice against challenge with P. c. adami DK and virulent P. c. chabaudi AS parasites",
abstract = "A current goal of malaria vaccine research is the development of vaccines that will cross-protect against multiple strains of malaria. Inthe present study, the breadth of cross-reactivity induced by a 30K multivalent DNA vaccine has been evaluated in susceptible A/J mice(H-2a) against infection with the Plasmodium chabaudi adami DK strain and a virulent parasite subspecies, Plasmodium chabaudi chabaudi AS. Immunized A/J mice were significantly protected against infection with both P. c. adami DK (31'40{\%} reduction in cumulativeparasitemia) and P. c. chabaudi AS parasites, where a 30'39{\%} reduction in cumulative parasitemia as well as enhanced survival wasobserved. The 30K vaccine-induced specific IFN-c production by splenocytes in response to native antigens from both P. c. chabaudi AS and P. c. adami DK. Specific antibodies reacting with surface antigens expressed on P. c. adami DS and P. c. chabaudi AS infected red blood cells, and with opsonizing properties, were detected. These results suggest that multivalent vaccines encoding conserved antigenscan feasibly induce immune cross-reactivity that span Plasmodium strains and subspecies and can protect hosts of distinct major histocompatibility complex haplotypes.",
keywords = "Open access version available",
author = "Tatiana Scorza and Kim Grubb and Mathieu Cambos and Cynthia Santamaria and D. Malu and Terry Spithill",
note = "Imported on 12 Apr 2017 - DigiTool details were: Journal title (773t) = International Journal for Parasitology. ISSNs: 0020-7519;",
year = "2008",
doi = "10.1016/j.ijpara.2007.10.009",
language = "English",
volume = "38",
pages = "819--827",
journal = "International Journal for Parasitology",
issn = "0020-7519",
publisher = "Elsevier",
number = "7",

}

Vaccination with a Plasmodium chabaudi adami multivalent DNA vaccine cross protects A/J mice against challenge with P. c. adami DK and virulent P. c. chabaudi AS parasites. / Scorza, Tatiana; Grubb, Kim; Cambos, Mathieu; Santamaria, Cynthia; Malu, D.; Spithill, Terry.

In: International Journal for Parasitology, Vol. 38, No. 7, 2008, p. 819-827.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Vaccination with a Plasmodium chabaudi adami multivalent DNA vaccine cross protects A/J mice against challenge with P. c. adami DK and virulent P. c. chabaudi AS parasites

AU - Scorza, Tatiana

AU - Grubb, Kim

AU - Cambos, Mathieu

AU - Santamaria, Cynthia

AU - Malu, D.

AU - Spithill, Terry

N1 - Imported on 12 Apr 2017 - DigiTool details were: Journal title (773t) = International Journal for Parasitology. ISSNs: 0020-7519;

PY - 2008

Y1 - 2008

N2 - A current goal of malaria vaccine research is the development of vaccines that will cross-protect against multiple strains of malaria. Inthe present study, the breadth of cross-reactivity induced by a 30K multivalent DNA vaccine has been evaluated in susceptible A/J mice(H-2a) against infection with the Plasmodium chabaudi adami DK strain and a virulent parasite subspecies, Plasmodium chabaudi chabaudi AS. Immunized A/J mice were significantly protected against infection with both P. c. adami DK (31'40% reduction in cumulativeparasitemia) and P. c. chabaudi AS parasites, where a 30'39% reduction in cumulative parasitemia as well as enhanced survival wasobserved. The 30K vaccine-induced specific IFN-c production by splenocytes in response to native antigens from both P. c. chabaudi AS and P. c. adami DK. Specific antibodies reacting with surface antigens expressed on P. c. adami DS and P. c. chabaudi AS infected red blood cells, and with opsonizing properties, were detected. These results suggest that multivalent vaccines encoding conserved antigenscan feasibly induce immune cross-reactivity that span Plasmodium strains and subspecies and can protect hosts of distinct major histocompatibility complex haplotypes.

AB - A current goal of malaria vaccine research is the development of vaccines that will cross-protect against multiple strains of malaria. Inthe present study, the breadth of cross-reactivity induced by a 30K multivalent DNA vaccine has been evaluated in susceptible A/J mice(H-2a) against infection with the Plasmodium chabaudi adami DK strain and a virulent parasite subspecies, Plasmodium chabaudi chabaudi AS. Immunized A/J mice were significantly protected against infection with both P. c. adami DK (31'40% reduction in cumulativeparasitemia) and P. c. chabaudi AS parasites, where a 30'39% reduction in cumulative parasitemia as well as enhanced survival wasobserved. The 30K vaccine-induced specific IFN-c production by splenocytes in response to native antigens from both P. c. chabaudi AS and P. c. adami DK. Specific antibodies reacting with surface antigens expressed on P. c. adami DS and P. c. chabaudi AS infected red blood cells, and with opsonizing properties, were detected. These results suggest that multivalent vaccines encoding conserved antigenscan feasibly induce immune cross-reactivity that span Plasmodium strains and subspecies and can protect hosts of distinct major histocompatibility complex haplotypes.

KW - Open access version available

U2 - 10.1016/j.ijpara.2007.10.009

DO - 10.1016/j.ijpara.2007.10.009

M3 - Article

VL - 38

SP - 819

EP - 827

JO - International Journal for Parasitology

JF - International Journal for Parasitology

SN - 0020-7519

IS - 7

ER -